+62.6%
GSK vs ALK
+16.0%
+46.6%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +0.6% | -0.8% | -0.2% |
| 7D | +1.7% | +9.0% | -7.4% | +1.2% |
| 30D | +7.0% | -1.6% | +8.7% | +7.0% |
| 3M | -2.7% | -23.2% | +20.5% | -1.5% |
| 6M | +1.4% | -3.9% | +5.3% | +1.3% |
| YTD | +5.3% | -22.6% | +27.9% | +5.5% |
| 1Y | +10.6% | -5.3% | +16.0% | +10.7% |
| 3Y | +62.6% | +18.6% | +44.0% | +60.2% |
| All | +62.6% | +16.0% | +46.6% | +60.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ALK.
Daily Out/Under-Performance
Portfolio return minus ALK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling